In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis

Drug Invention Today

Volumn 5, Issue 1, 2013, Pages 8-12

  Alam, Md Sarfaraz ^a   Ali, Md Sajid ^a   Alam, Nawazish ^b   Siddiqui, Masoom Raza ^c   Shamim, Md ^d   Safhi, M M ^a  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b SBS College of pharmacy   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Shivdan Singh Institute of Technology and Management   (India)

Author keywords

Anti inflammatory study; Clobetasol propionate; Contact dermatitis; In vivo study; Nanoemulsion

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALCOHOL; CLOBETASOL PROPIONATE; COSURFACTANT; EUCALYPTUS OIL; NUCLEOSIDE TRIPHOSPHATASE; PLACEBO; POLYSORBATE 20; SURFACTANT; WATER; WATER OIL CREAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CREAM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENZYME ACTIVITY; FEMALE; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; MALE; NANOEMULSION; NONHUMAN; PROTEIN HYDROLYSIS; PSORIASIS; RAT; SKIN IRRITATION; TITRIMETRY; TOPICAL TREATMENT;

EID: 84911980762     PISSN: 09757619     EISSN: 09757619     Source Type: Journal    
DOI: 10.1016/j.dit.2013.02.001     Document Type: Article

References (21)

1. Senyigit T., Padula C., özer O., Santi P. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm 2009, 380:155-160.
2. Hengge U.R., Ruzicka T., Schwartz R.A., Cork M.J. Adverse effects of topical glucocorticosteroids. J Am Acad Derm 2006, 54:1-15.
3. Baboota S., Alam M.S., Sharma S., Kaur S.J., Anil K., Ali J. Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis. Int J Pharma Investig 2011, 1:139-147.
4. Marchiori M.L., Lubini G., Nora G.D., et al. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization and in vitro drug release study. Drug Dev Ind Pharm 2010, 36:962-971.
5. Ali M.S., Alam M.S., Alam N., Alam M.I., Imam F., Ali M.D. Formulation, characterization and in-vivo study of nanoemulsion topical gel of beclomethasone dipropionate for psoriasis. WJPPS 2012, 1(3):839-857.
6. Alam M.S., Baboota S., Ali M.S., et al. Accelerated stability testing of betamethasone dipropionate nanoemulsion. Int J Pharm Pharm Sci 2012, 4(4):371-374.
7. Kotta S., Khan A.W., Pramod K., Ansari S.H., Sharma R.K., Ali J. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 2012, 9(5):585-598.
8. Gordon M.L. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses. Clin Ther 1998, 20(1):26-39.
9. Parveen R., Baboota S., Ali J., Ahuja A., Vasudev S.S., Ahmad S. Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm 2011, 413(1-2):245-253.
10. Shakeel F., Ramadan W., Gargum H.M., Singh R. Preparation and in vivo evaluation of indomethacin loaded true nanoemulsions. Sci Pharm 2009, 78:47-56.
11. Senyigit T., Sonvico F., Barbieri S., Ozer O., Santi P., Colombo P. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010, 142:368-373.
12. Di Virgilio F., Chiozzi P., Ferrari D., et al. Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Blood 2001, 97:587-600.
13. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004, 240:301-304.
14. Ralevic V., Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 2003, 16:133-140.
15. Alam M.S., Ali M.S., Shamim M., Hussain M.S., Ali M.M., Alam N. Preparation, characterization and in vitro irritation study of clobetasol propionate loaded nanoemulsion for psoriasis and atopic dermatitis. WJPPS 2012, 1(4):1189-1208.
16. Fontana M.C., Rezer J.F.P., Coradini K., Leal D.B.R., Beck R.C.R. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 2011, 79:241-249.
17. Seidenari S., Di Nardo A., Giannetti A. Assessment of topical corticosteroid activity on experimentally induced contact dermatitis: echographic evaluation with binary transformation and image analysis. Skin Pharmacol 1993, 6(2):85-91.
18. Bradford M.M.A. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
19. Alam M.S., Ali M.S., Alam N., et al. Design and characterization nanostructure topical gel of betamethasone dipropionate for psoriasis. J App Pharm Sci 2012, 2(10):148-158.
20. Van-Abbe N.J., Nicholas P., Boon E. Exaggerated exposure in topical irritancy and sensitization testing. J Soc Cosmet Chem 1975, 26:173-187.
21. Silva J., Abebe W., Sousa S.M., Duarte V.G., Machado M.I., Matos F.J. Analgesic and antiinflammatory effects of essential oils of Eucalyptus. J Ethnopharmacol 2003, 89(2-3):277-283.